TNIK and helminthiasis: To test the efficacy of TNIK inhibition in these models, we focused on two prototypical inhibitors: NCB0846 (NCB), which has been tested preclinically[5] and mebendazole (MBZ), which is approved by the FDA for treatment of helminth infections.